S. Diessl

Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.

A. Buck, M. Luster, C. Reiners, 2013, The Journal of clinical endocrinology and metabolism.

Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma

A. Buck, C. Reiners, J. A. Smit, 2012, Clinical endocrinology.

Patients with recurrent glioblastoma multiforme

C. Reiners, M. Flentje, S. Samnick, 2013, Nuklearmedizin.

Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level

C. Reiners, V. Drozd, F. Verburg, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancer.

S. Rivkees, C. Reiners, V. Drozd, 2011, The Journal of clinical endocrinology and metabolism.

Improved follow-up of patients with differentiated thyroid carcinoma

A. Buck, C. Reiners, F. Verburg, 2013, Nuklearmedizin.

Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.

A. Buck, M. Luster, C. Reiners, 2013, The Journal of clinical endocrinology and metabolism.